The ACC.org editors have created additional prevention-related content meant to reinforce the teaching points and education presented during ACC.17. View these featured prevention learning pathway presentations available in iScience, the ACC.17 Meeting on Demand™ Program: The Evolution of PCSK9 Inhibitors: Pipedream or Evidence-Based Reality? by Evan Stein, MD, PhD. Also check out a patient case quiz on non-statin therapy use in a patient with clinical atherosclerotic cardiovascular disease and very high LDL-C. The ACC.17 Meeting Coverage Page contains full coverage of the prevention post-ACC.17 content. Visit the Prevention Clinical Topic Collection on ACC.org for the latest prevention science and news.